Brief: Xspray Pharma Re-Submits FDA Application For Dasynoc

Xspray Pharma publ AB

26/02/2026 15:05

Feb 26 (Reuters) - XSpray Pharma AB (publ) XSPRAY.ST:

RE-SUBMITS ITS FDA APPLICATION FOR DASYNOC

WE MAINTAIN OUR PLAN TO LAUNCH TWO PRODUCTS, DASYNOC AND XS003 NILOTINIB DURING SECOND HALF OF 2026

NEW PDUFA-DATE IS EXPECTED TO BE SET FOR AUGUST 2026 AT LATEST

Source text: ID:nMFNbK0qZZ

Further company coverage: XSPRAY.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))